JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ameyar, M.
Right arrow Articles by Chouaïb, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ameyar, M.
Right arrow Articles by Chouaïb, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 44, 29002-29008, October 30, 1998

Analysis of Human Breast Adenocarcinoma MCF7 Resistance to Tumor Necrosis Factor-induced Cell Death
LACK OF CORRELATION BETWEEN JNK ACTIVATION AND CERAMIDE PATHWAY

Maya AmeyarDagger , Azeddine Atfi, Zhenzi CaiDagger , Rodica StancouDagger , Vladimir ShatrovDagger , Ali Bettaïeb**, and Salem ChouaïbDagger

From the Dagger  INSERM U487 Cytokines et Immunologie des Tumeurs Humaines, Institut Gustave Roussy, 94805 Villejuif,  INSERM U482, Institut Fédératif de Recherche du Centre Hospitalo-Universitaire Saint-Antoine, 75012 Paris, and ** INSERM CJF 95-03, Institut Claudius Régaud, 31052 Toulouse, France

Considerable progress has been made in the understanding of tumor necrosis factor (TNF) signaling; however, the molecular and biochemical basis of tumor resistance to the cytotoxic action of TNF are still not definitively identified yet. Although a role of c-Jun N-terminal kinase (JNK) pathway has been suggested as an effector in TNF signaling, its exact relative contribution and its interaction with ceramide pathway and tumor resistance to TNF remain unknown. The relationship between JNK activation and human breast adenocarcinoma MCF7 resistance acquisition to the cytotoxic action of TNF was therefore investigated. We demonstrate that TNF triggers JNK activation in both TNF-sensitive MCF7 cells and its resistant derivative, RA1/1001. In addition, when MCF7 cells were stably transfected with mitogen-activated protein kinase kinase 4 (MKK4) dominant-negative cDNA or transiently transfected with a dominant-negative c-Jun mutant (TAM 67), their susceptibility to the cytotoxic action of TNF remains comparable with control cells. We also demonstrated that JNK activation does not require ceramide generation since in MCF7 cells transfected with a dominant-negative derivative of FADD (FADD-DN), which are resistant to the cytotoxic action of TNF, TNF induced JNK activation in the absence of ceramide generation. Furthermore, our data indicate that exogenous permeable synthetic ceramide C-6 induced the killing of MCF7 cells transfected with MKK4 dominant-negative cDNA. These results provide strong evidence indicating that tumor acquisition of resistance to the cytotoxic action of TNF may occur either independently or at a level downstream of JNK activation and suggest that JNK activation is not linked to ceramide pathway in TNF-mediated apoptosis.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
R. Simstein, M. Burow, A. Parker, C. Weldon, and B. Beckman
Apoptosis, Chemoresistance, and Breast Cancer: Insights From the MCF-7 Cell Model System
Experimental Biology and Medicine, October 1, 2003; 228(9): 995 - 1003.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. D. Major and B. A. Wolf
Interleukin-1{beta} Stimulation of c-Jun NH2-Terminal Kinase Activity in Insulin-Secreting Cells: Evidence for Cytoplasmic Restriction
Diabetes, December 1, 2001; 50(12): 2721 - 2728.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. K. Manna, N. K. Sah, and B. B. Aggarwal
Protein Tyrosine Kinase p56lck Is Required for Ceramide-induced but Not Tumor Necrosis Factor-induced Activation of NF-kappa B, AP-1, JNK, and Apoptosis
J. Biol. Chem., April 28, 2000; 275(18): 13297 - 13306.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Erdreich-Epstein, H. Shimada, S. Groshen, M. Liu, L. S. Metelitsa, K. S. Kim, M. F. Stins, R. C. Seeger, and D. L. Durden
Integrins {{alpha}}v{beta}3 and {{alpha}}v{beta}5 Are Expressed by Endothelium of High-Risk Neuroblastoma and Their Inhibition Is Associated with Increased Endogenous Ceramide
Cancer Res., February 1, 2000; 60(3): 712 - 721.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.